Several novel medications are now present in the United Kingdom for managing type 2 diabetes . Wegovy , Rybelsus , and Trulicity represent unique approaches, with Saxenda and Trulicity being injectable peptide receptor mimics primarily aimed at fat reduction alongside glucose control , while Metf